查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2000739

筆式注射針市場：2026-2032年全球市場預測（按產品、類型、針頭長度、分銷管道、應用和最終用戶分類）

Pen Needles Market by Product, Type, Needle Length, Distribution Channels, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，筆式注射針市場價值將達到 22.2 億美元，到 2026 年將成長至 24.3 億美元，到 2032 年將達到 43.3 億美元，複合年成長率為 9.98%。

主要市場統計數據
基準年 2025 22.2億美元
預計年份：2026年 24.3億美元
預測年份：2032年 43.3億美元
複合年成長率 (%) 9.98%

全面概述筆式注射針市場的核心促進因素、引入模式、臨床趨勢和新興安全考量。

引言部分為理解目前筆式注射針市場的複雜趨勢奠定了基礎。透過對臨床應用模式的深入檢驗，引言揭示了影響醫護人員和患者的各種因素。該分析重點闡述了安全考量如何演變為產品開發和採購決策的關鍵驅動力。隨著本章的展開，我們將著重強調技術創新在塑造性能預期和闡明改善患者療效途徑的重要性。

探索技術、臨床實踐、法規結構和患者偏好的變革性變化，這些變化將塑造筆式注射針的未來。

本節從多個角度探討了正在重塑筆式注射器領域的變革性變化。首先，我們將追溯數位化整合的影響，其中連接性和智慧型裝置正在重新定義使用者體驗和數據驅動型醫療。隨著遠端醫療的擴展，筆式注射器製造商正與軟體開發商合作，以確保無縫的互通性和遠端監測功能。因此，傳統的產品生命週期正在向加速創新週期轉變，該週期優先考慮患者參與度、治療依從性和療效評估。

對美國將於 2025 年推出的關稅對供應鏈韌性、成本結構和市場競爭的多層次影響進行全面分析。

對2025年實施的新關稅進行深入分析後發現，這些關稅對成本結構和競爭產生了多方面的影響。這些關稅最初旨在加強國內製造業，但卻導致許多依賴跨境供應鏈的企業原料和物流成本上升。因此，企業正在重新評估籌資策略，並尋求其他區域供應商以減輕進口成本增加的財務負擔。

對筆式注射針的關鍵細分市場進行詳細分析：按產品類型、針頭長度、分銷管道、應用和最終用戶說明差異。

對注射筆針細分市場的詳細分析揭示了該產品線如何滿足各種臨床和商業性需求。安全型注射筆針和標準型注射筆針針對不同的風險狀況。前者配備了防護罩和回縮機制，以減少意外傷害，而後者在成本敏感的情況下仍可作為基本解決方案。從使用模式來看，一次性注射筆針和可重複使用注射筆針的選擇反映了便利性和長期成本效益之間的權衡。可重複使用系統可透過多次給藥節省成本，但需要嚴格的消毒通訊協定，這會影響工作流程和病患教育。

區域洞察：美洲、歐洲、中東和非洲以及亞太地區的需求促進因素、供應鏈趨勢和成長機會

區域性研究揭示了地域差異如何影響需求趨勢和供應鏈策略。在美洲，為因應慢性病高發生問題而採取的大力措施，輔以完善的經銷網路和健全的報銷機制，正推動著筆式注射器的穩定需求。電子商務的興起加速了宅配模式的發展，而藥品生產商與藥品福利管理機構（PBM）之間的合作則確保了處方藥清單和定價結構的統一性。

深入剖析領先的筆式注射針製造商的策略定位、產品創新、合作夥伴關係和成長方式，揭示其引人入勝的公司洞察。

主要的筆式注射針製造商正採取多元化策略來確保競爭優勢並拓展產品系列。對研發的大量投入促成了新一代塗層技術的開發，這些技術能夠提升注射針的滑動性能並減輕患者的不適感。同時，多家公司正與技術供應商建立策略夥伴關係，以整合連接功能，從而實現劑量追蹤和用藥依從性監測。

為指導產業領導者開展筆式注射針應用的策略性舉措、夥伴關係和創新投資提供實用建議。

為了在瞬息萬變的筆式注射針市場取得成功，產業領導者必須採取一系列有針對性的措施，在創新與嚴格的操作流程之間取得平衡。透過先進的設計和防護機制來提升安全性，他們可以滿足患者和醫療專業人員日益成長的期望。整合數位化追蹤功能有助於更深入地了解患者的治療依從性。同時，透過區域供應商和雙重採購安排實現採購多元化，可以減輕貿易政策變化帶來的影響。

針對筆式注射針研究，提出了一套全面的調查方法，概述了資料收集技術、檢驗過程和品質保證通訊協定。

本報告的調查方法結合了全面的資料收集技術和嚴格的檢驗流程，以確保其準確性和有效性。關鍵見解是透過對多個地區的臨床專家、採購經理和監管專家進行深入訪談而獲得的。除了這些一線觀點外，還廣泛查閱了同行評審的科學文獻、技術白皮書、專利申請和產品規格。

本總結主要發現、趨勢、策略挑戰和未來方向，基於與筆式注射針生態系統相關人員的討論。

本結論部分總結了分析中湧現的關鍵主題和策略挑戰。安全改進和人體工學創新已從漸進式改進轉變為競爭差異化的核心要素。不斷變化的法規持續提高材料和可追溯性標準，迫使利害關係人投資於流程改進和協作倡導。近期貿易政策變化帶來的外溢效應凸顯了敏捷供應鏈結構和多角化採購模式的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 筆式注射針市場：依產品分類

  • 安全筆針
  • 標準筆針

第9章 筆式注射針市場：按類型分類

  • 一次性的
  • 可重複使用的

第10章 筆式注射針市場：依針頭長度分類

  • 10 mm
  • 12 mm
  • 4 mm
  • 5 mm
  • 6 mm
  • 8 mm

第11章 筆式注射針市場：依通路分類

  • 醫院藥房
  • 線上平台
  • 零售藥房

第12章 筆式注射針市場：依應用領域分類

  • Glucagon-Like Peptide-1療法
  • 荷爾蒙補充療法
  • 胰島素輸送

第13章 筆式注射針市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第14章 筆注射針市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 筆式注射針市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 筆注射針市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國筆式注射針市場

第18章：中國筆式皮下注射針市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AdvaCare Pharma
  • Advocate by Pharma Supply, Inc.
  • Allison Medical, Inc.
  • ARKRAY, Inc.
  • Ayset Health Services
  • B. Braun SE
  • Becton, Dickinson and Company
  • Berpu Medical Technology Co., Ltd.
  • Cardinal Health, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gan & Lee Pharmaceuticals Co., Ltd.
  • GlucoRx Ltd.
  • Hindustan Syringes & Medical Devices Ltd.
  • IME-DC GmbH
  • Jiangsu Micsafe Medical Technology Co., Ltd.
  • Jinan Babio BIoTechnology Co., Ltd.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medexel Co., Ltd.
  • Medical Technology and Devices SpA
  • MEDISEC Healthcare
  • Montmed Inc.
  • Narang Medical Limited
  • Neon Diagnostics Ltd.
  • Nipro Corporation
  • Novo Nordisk A/S
  • Owen Mumford Limited
  • Promisemed Medical Devices Inc.
  • Shanghai Berpu Medical Co., Ltd
  • Shanghai Kindly Enterprise Development Group
  • Sol-Millennium
  • Spirit Healthcare Pty Ltd.
  • Terumo Corporation
  • Trividia Health, Inc.
  • UltiMed, Inc.
  • Van Heek Medical
  • Vitrex Medical A/S
  • Vogt Medical Vertrieb GmbH
  • Ypsomed Holding AG
  • Zibo Sunrise Medical Co., Ltd.
Product Code: MRR-02026C4C925F

The Pen Needles Market was valued at USD 2.22 billion in 2025 and is projected to grow to USD 2.43 billion in 2026, with a CAGR of 9.98%, reaching USD 4.33 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.22 billion
Estimated Year [2026] USD 2.43 billion
Forecast Year [2032] USD 4.33 billion
CAGR (%) 9.98%

Comprehensive Introduction Illuminating Core Drivers Adoption Patterns Clinical Dynamics and Emerging Safety Considerations in the Pen Needle Landscape

The introductory section lays the foundation for understanding the complex dynamics that define the current pen needle environment. Through a thorough examination of clinical adoption patterns, the narrative unveils the driving factors influencing both healthcare professionals and patients. This exploration reveals how safety considerations have evolved into a pivotal force guiding product development and procurement decisions. As the chapter unfolds, it underscores the significance of technological innovation in shaping performance expectations and illuminating pathways to improved patient outcomes.

Furthermore, the introduction highlights the interplay between end-user requirements and regulatory standards. It examines how heightened scrutiny around needle safety, combined with the imperative to reduce needlestick injuries, has spurred manufacturers to embrace advanced materials and design enhancements. Against this backdrop, evolving healthcare delivery models and telehealth initiatives have accelerated demand for user-friendly devices that support self-administration. By capturing these emerging trends, the introduction not only contextualizes the subsequent analysis but also underscores the urgency for stakeholders to align product portfolios with the shifting priorities of clinicians, payers, and patients.

Exploration of Transformative Shifts in Technology Clinical Practices Regulatory Frameworks and Patient Preferences Shaping the Future of Pen Needle Use

This section explores the transformative shifts that are reshaping the pen needle sphere on multiple fronts. It begins by tracing the impact of digital integration, where connectivity features and smart devices are redefining user experience and data-driven care. As telemedicine expands, pen needle manufacturers are collaborating with software developers to ensure seamless interoperability and remote monitoring capabilities. Consequently, traditional product lifecycles are giving way to accelerated innovation cycles that prioritize patient engagement, treatment adherence, and outcome measurement.

In parallel, regulatory evolution is playing a central role. Stricter guidelines on materials, sterilization processes, and waste management are compelling industry participants to refine manufacturing techniques and strengthen traceability. Meanwhile, patient preferences have pivoted toward minimally invasive solutions that minimize discomfort and anxiety, prompting a wave of ergonomic redesigns. These interdependent drivers-technology, regulation, and consumer behavior-are converging to create an environment where agility and collaboration become essential. As a result, stakeholders must navigate a landscape marked by rapid change, continuous feedback loops, and an unrelenting focus on safety and efficacy.

Comprehensive Analysis of the Layered Effects of the United States Tariffs Introduced in 2025 on Supply Chain Resilience Cost Structures and Market Competition

A focused analysis of the new tariffs enacted in the United States in 2025 uncovers their layered effects on cost structures and competitive dynamics. Initially designed to bolster domestic manufacturing, the duties have led to an uptick in raw material expenses and logistical overhead for many companies reliant on cross-border supply chains. The result has been a recalibration of sourcing strategies, with manufacturers exploring alternative regional suppliers to mitigate the financial strain imposed by increased import costs.

Transitioning from traditional procurement models, several organizations are piloting dual-sourcing initiatives to strengthen resilience and preserve margin integrity. At the same time, strategic stockpiling has emerged as a temporary buffer, though it carries its own working capital trade-offs. On the demand side, some buyers are extending contract negotiations to secure favorable terms, shifting pressure back onto the supplier community to absorb a portion of the tariff impact. Against this backdrop, smaller players face heightened challenges in retaining profitability, while larger entities are leveraging economies of scale and robust negotiation capacities to sustain their competitive edge.

Looking ahead, collaborative engagement with policymakers and participation in industry coalitions will be critical to influencing future adjustments to tariff regimes. Those that adapt through dynamic sourcing, supply chain transparency, and targeted cost optimization will be best positioned to navigate the ongoing ripple effects of the 2025 duties.

Deep Dive into Essential Segmentation of Pen Needles Explaining Variations across Product Types Needle Lengths Distribution Channels Applications and End Users

A deep dive into pen needle segmentation reveals the nuanced ways that product offerings align with varied clinical and commercial requirements. Safety pen needles and standard pen needles each address distinct risk profiles, with the former incorporating protective shields and retraction mechanisms to reduce accidental injuries, while the latter continue to serve as a baseline solution in cost-sensitive contexts. Shifting to usage models, the choice between disposable and reusable pen needles reflects a trade-off between convenience and long-term cost efficiency. Reusable systems, while offering potential savings through multiple administrations, demand rigorous sterilization protocols that influence workflow and patient education.

Needle length preferences further demonstrate the granularity of end-user needs, spanning ultra-short options for minimal invasiveness to longer configurations for thicker tissue applications. Short lengths like four and five millimeters have gained traction among patients seeking reduced pain, whereas ten and twelve millimeter variants remain essential for specific therapeutic contexts. Distribution pathways also delineate market distinctions: hospital pharmacies prioritize safety and regulatory compliance, online platforms cater to direct-to-patient convenience, and retail pharmacies balance accessibility with professional oversight.

On the clinical front, applications such as glucagon-like peptide-1 therapy, hormone replacement therapy, and insulin delivery each drive unique demand patterns, with dosing precision and comfort serving as critical differentiators. Finally, end-user settings including ambulatory surgical centers, clinics, and hospitals underscore the importance of custom-tailored solutions that match procedural workflows, staff training capabilities, and patient throughput demands.

Regional Insights Exploring Demand Drivers Supply Chain Dynamics and Growth Opportunities across Americas Europe Middle East Africa and Asia-Pacific

Regional insights illuminate how geographic distinctions shape demand trajectories and supply chain strategies. Within the Americas, strong initiatives to confront chronic disease prevalence are driving consistent demand for pen needle devices, supported by well-established distribution networks and robust reimbursement frameworks. E-commerce adoption is accelerating home-delivery models, while partnerships between manufacturers and pharmacy benefit managers ensure alignment on formularies and pricing structures.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts are influencing product approvals and market entry tactics. In many countries, public health programs subsidize access to advanced delivery systems, fostering broader adoption among patient populations. Emerging markets in the region are experiencing infrastructure upgrades and expanding clinical care capacity, creating new avenues for localized production and strategic alliances.

In the Asia-Pacific region, rising rates of metabolic disorders combined with improvements in healthcare infrastructure are fueling growth. Investments in cold chain logistics and rural outreach programs are enabling wider device penetration. Moreover, regional manufacturers are increasingly pursuing collaborations with global technology leaders to integrate digital health solutions into traditional pen needle offerings. These concerted efforts across three major regions underscore the importance of tailored strategies that reflect local regulatory landscapes, patient behaviors, and distribution dynamics.

Compelling Company Insights Unveiling Strategic Positioning Product Innovations Collaborations and Growth Approaches among Leading Pen Needle Manufacturers

Leading pen needle manufacturers are undertaking multifaceted strategies to secure competitive advantage and extend product portfolios. Significant investments in research and development have yielded next-generation coatings that enhance glide performance and reduce patient discomfort. Concurrently, several companies have entered into strategic collaborations with technology providers to embed connectivity features that enable dosage tracking and adherence monitoring.

Within the competitive arena, mergers and acquisitions are reshaping the industry landscape by consolidating capabilities in safety engineering and manufacturing scale. Partnerships with contract development and manufacturing organizations are also proliferating, offering flexibility in meeting fluctuating demand while preserving capital. These alliances often incorporate shared risk-reward models that incentivize accelerated product launches and joint marketing initiatives.

On the innovation front, select players are piloting biodegradable needle materials and advanced tip geometries aimed at minimizing tissue trauma. At the same time, forward-leaning companies are establishing virtual training platforms for clinicians and patients, thereby differentiating their offerings through value-added services. Taken together, these corporate maneuvers reflect a dual focus on core technological differentiation and strategic ecosystem engagement to drive sustainable growth.

Actionable Recommendations to Guide Industry Leaders through Strategic Initiatives Partnerships and Innovation Investments in Pen Needle Applications

To thrive in the evolving pen needle environment, industry leaders must adopt a series of targeted actions that balance innovation with operational rigor. Emphasizing safety enhancements through advanced tip designs and protective mechanisms will address rising patient and provider expectations, while integration of digital tracking features can foster deeper engagement around treatment adherence. Simultaneously, diversification of sourcing through regional suppliers and dual-sourcing arrangements will mitigate the impact of trade policy shifts.

Manufacturers should deepen collaborations with payers and healthcare systems to secure favorable reimbursement pathways, leveraging real-world evidence to demonstrate value in outcomes and cost of care. Expanding educational programs for patients and clinicians through digital learning platforms will reinforce proper usage techniques, reduce adverse events, and drive brand loyalty. Additionally, prioritizing sustainability initiatives-such as recyclable materials and responsible waste management-will resonate with growing stakeholder focus on environmental stewardship.

Finally, a strategic expansion into underserved markets, supported by localized partnerships and distribution networks, will unlock new revenue streams. By coupling these initiatives with robust performance metrics and agile decision-making frameworks, stakeholders can capture emerging opportunities while maintaining resilience against regulatory and economic headwinds.

Comprehensive Research Methodology Outlining Data Collection Techniques Validation Processes and Quality Assurance Protocols Applied to Pen Needle Studies

The research methodology underpinning this report combined comprehensive data collection techniques with rigorous validation processes to ensure accuracy and relevance. Primary insights were gathered through in-depth interviews with clinical experts, procurement executives, and regulatory specialists spanning multiple regions. These firsthand perspectives were complemented by an extensive review of peer-reviewed scientific literature, technical white papers, patent filings, and product specifications.

Secondary research encompassed a systematic analysis of public company disclosures, healthcare agency guidelines, and industry association publications. This multifaceted approach enabled triangulation of findings, enhancing the reliability of trend identification and competitive benchmarking. Quality assurance protocols included cross-referencing key data points across sources and subjecting draft conclusions to expert panel review. Any discrepancies or outlier observations prompted additional validation steps, ensuring that the final insights rest on a solid evidentiary foundation.

Together, these methodological pillars support a comprehensive understanding of the pen needle landscape, delivering actionable intelligence for decision makers seeking to navigate complex market dynamics.

Conclusive Perspectives Summarizing Key Findings Trends Strategic Imperatives and the Path Forward for Stakeholders Engaged in the Pen Needle Ecosystem

This concluding section synthesizes the critical themes and strategic imperatives that emerge from the analysis. Safety advancements and ergonomic innovations have transitioned from incremental improvements to central elements of competitive differentiation. Regulatory evolution continues to drive higher standards for materials and traceability, compelling players to invest in process enhancements and collaborative advocacy. The ripple effects of recent trade policy changes underscore the importance of agile supply chain architectures and diversified procurement models.

Segmentation insights highlight the multifaceted nature of customer needs, spanning product design, delivery formats, and end-user environments. Regional nuances further reinforce the value of localized strategies that respect regulatory idiosyncrasies and patient preferences. Leading organizations are responding with robust R&D pipelines, strategic partnerships, and integrated digital offerings that align with broader healthcare trends toward personalized, data-driven care.

Looking ahead, success in this domain will depend on the ability to align innovation with stakeholder expectations, leverage evidence-based value propositions, and cultivate resilient operational ecosystems. By embracing these imperatives, decision makers can shape a future where pen needle solutions not only deliver therapeutic efficacy but also elevate patient experiences and contribute to sustainable growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pen Needles Market, by Product

  • 8.1. Safety Pen Needles
  • 8.2. Standard Pen Needles

9. Pen Needles Market, by Type

  • 9.1. Disposable
  • 9.2. Reusable

10. Pen Needles Market, by Needle Length

  • 10.1. 10 mm
  • 10.2. 12 mm
  • 10.3. 4 mm
  • 10.4. 5 mm
  • 10.5. 6 mm
  • 10.6. 8 mm

11. Pen Needles Market, by Distribution Channels

  • 11.1. Hospital Phrmacies
  • 11.2. Online Platforms
  • 11.3. Retail Pharmacies

12. Pen Needles Market, by Application

  • 12.1. Glucagon-like Peptide-1 Therapy
  • 12.2. Hormone Replacement Therapy
  • 12.3. Insulin Delivery

13. Pen Needles Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Clinics
  • 13.3. Hospitals

14. Pen Needles Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Pen Needles Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Pen Needles Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Pen Needles Market

18. China Pen Needles Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. AdvaCare Pharma
  • 19.6. Advocate by Pharma Supply, Inc.
  • 19.7. Allison Medical, Inc.
  • 19.8. ARKRAY, Inc.
  • 19.9. Ayset Health Services
  • 19.10. B. Braun SE
  • 19.11. Becton, Dickinson and Company
  • 19.12. Berpu Medical Technology Co., Ltd.
  • 19.13. Cardinal Health, Inc.
  • 19.14. F. Hoffmann-La Roche Ltd.
  • 19.15. Gan & Lee Pharmaceuticals Co., Ltd.
  • 19.16. GlucoRx Ltd.
  • 19.17. Hindustan Syringes & Medical Devices Ltd.
  • 19.18. IME-DC GmbH
  • 19.19. Jiangsu Micsafe Medical Technology Co., Ltd.
  • 19.20. Jinan Babio Biotechnology Co., Ltd.
  • 19.21. Lepu Medical Technology (Beijing) Co., Ltd.
  • 19.22. Medexel Co., Ltd.
  • 19.23. Medical Technology and Devices S.p.A.
  • 19.24. MEDISEC Healthcare
  • 19.25. Montmed Inc.
  • 19.26. Narang Medical Limited
  • 19.27. Neon Diagnostics Ltd.
  • 19.28. Nipro Corporation
  • 19.29. Novo Nordisk A/S
  • 19.30. Owen Mumford Limited
  • 19.31. Promisemed Medical Devices Inc.
  • 19.32. Shanghai Berpu Medical Co., Ltd
  • 19.33. Shanghai Kindly Enterprise Development Group
  • 19.34. Sol-Millennium
  • 19.35. Spirit Healthcare Pty Ltd.
  • 19.36. Terumo Corporation
  • 19.37. Trividia Health, Inc.
  • 19.38. UltiMed, Inc.
  • 19.39. Van Heek Medical
  • 19.40. Vitrex Medical A/S
  • 19.41. Vogt Medical Vertrieb GmbH
  • 19.42. Ypsomed Holding AG
  • 19.43. Zibo Sunrise Medical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PEN NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PEN NEEDLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PEN NEEDLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PEN NEEDLES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PEN NEEDLES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PEN NEEDLES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PEN NEEDLES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PEN NEEDLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PEN NEEDLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PEN NEEDLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PEN NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PEN NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PEN NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PEN NEEDLES MARKET SIZE, BY SAFETY PEN NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PEN NEEDLES MARKET SIZE, BY SAFETY PEN NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PEN NEEDLES MARKET SIZE, BY SAFETY PEN NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PEN NEEDLES MARKET SIZE, BY STANDARD PEN NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PEN NEEDLES MARKET SIZE, BY STANDARD PEN NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PEN NEEDLES MARKET SIZE, BY STANDARD PEN NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PEN NEEDLES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PEN NEEDLES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PEN NEEDLES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PEN NEEDLES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PEN NEEDLES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PEN NEEDLES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PEN NEEDLES MARKET SIZE, BY 10 MM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PEN NEEDLES MARKET SIZE, BY 10 MM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PEN NEEDLES MARKET SIZE, BY 10 MM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PEN NEEDLES MARKET SIZE, BY 12 MM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PEN NEEDLES MARKET SIZE, BY 12 MM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PEN NEEDLES MARKET SIZE, BY 12 MM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PEN NEEDLES MARKET SIZE, BY 4 MM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PEN NEEDLES MARKET SIZE, BY 4 MM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PEN NEEDLES MARKET SIZE, BY 4 MM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PEN NEEDLES MARKET SIZE, BY 5 MM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PEN NEEDLES MARKET SIZE, BY 5 MM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PEN NEEDLES MARKET SIZE, BY 5 MM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PEN NEEDLES MARKET SIZE, BY 6 MM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PEN NEEDLES MARKET SIZE, BY 6 MM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PEN NEEDLES MARKET SIZE, BY 6 MM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PEN NEEDLES MARKET SIZE, BY 8 MM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PEN NEEDLES MARKET SIZE, BY 8 MM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PEN NEEDLES MARKET SIZE, BY 8 MM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PEN NEEDLES MARKET SIZE, BY HOSPITAL PHRMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PEN NEEDLES MARKET SIZE, BY HOSPITAL PHRMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PEN NEEDLES MARKET SIZE, BY HOSPITAL PHRMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PEN NEEDLES MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PEN NEEDLES MARKET SIZE, BY ONLINE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PEN NEEDLES MARKET SIZE, BY ONLINE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PEN NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PEN NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PEN NEEDLES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PEN NEEDLES MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PEN NEEDLES MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PEN NEEDLES MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PEN NEEDLES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEN NEEDLES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEN NEEDLES MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PEN NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PEN NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PEN NEEDLES MARKET SIZE, BY INSULIN DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PEN NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PEN NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PEN NEEDLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PEN NEEDLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PEN NEEDLES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PEN NEEDLES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PEN NEEDLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PEN NEEDLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PEN NEEDLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PEN NEEDLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS PEN NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PEN NEEDLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PEN NEEDLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 132. GCC PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 134. GCC PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 153. G7 PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. G7 PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 155. G7 PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 156. G7 PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. G7 PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. NATO PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 162. NATO PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 163. NATO PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. NATO PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PEN NEEDLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES PEN NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA PEN NEEDLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA PEN NEEDLES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA PEN NEEDLES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA PEN NEEDLES MARKET SIZE, BY NEEDLE LENGTH, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA PEN NEEDLES MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA PEN NEEDLES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA PEN NEEDLES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)